Snyder CL - Search Results

1

Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.

Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS. Lynch HT, et al. Among authors: snyder cl. J Clin Oncol. 2003 Feb 15;21(4):740-53. doi: 10.1200/JCO.2003.05.096. J Clin Oncol. 2003. PMID: 12586815 Review.

2

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.

Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Lynch HT, et al. Cancer Genet Cytogenet. 2006 Mar;165(2):91-7. doi: 10.1016/j.cancergencyto.2005.07.011. Cancer Genet Cytogenet. 2006. PMID: 16527602

3

Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.

Silva E, Gatalica Z, Snyder C, Vranic S, Lynch JF, Lynch HT. Silva E, et al. Breast J. 2008 Jan-Feb;14(1):14-24. doi: 10.1111/j.1524-4741.2007.00516.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086271

4

Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Lynch HT, Silva E, Snyder C, Lynch JF. Lynch HT, et al. Breast J. 2008 Jan-Feb;14(1):3-13. doi: 10.1111/j.1524-4741.2007.00515.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086272 Review.

5

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, Schildkraut J, Daly MB, Isaacs C, Pichert G, Neuhausen SL, Couch FJ, van't Veer L, Eeles R, Bancroft E, Evans DG, Ganz PA, Tomlinson GE, Narod SA, Matloff E, Domchek S, Rebbeck TR. Finkelman BS, et al. J Clin Oncol. 2012 Apr 20;30(12):1321-8. doi: 10.1200/JCO.2011.37.8133. Epub 2012 Mar 19. J Clin Oncol. 2012. PMID: 22430266 Free PMC article.

6

Hereditary breast cancer: practical pursuit for clinical translation.

Lynch HT, Snyder C, Lynch J. Lynch HT, et al. Ann Surg Oncol. 2012 Jun;19(6):1723-31. doi: 10.1245/s10434-012-2256-z. Epub 2012 Mar 21. Ann Surg Oncol. 2012. PMID: 22434244 Review.

7

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Metcalfe K, et al. JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658. JAMA Oncol. 2015. PMID: 26181175

8

Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.

Watson P, Narod SA, Fodde R, Wagner A, Lynch JF, Tinley ST, Snyder CL, Coronel SA, Riley B, Kinarsky Y, Lynch HT. Watson P, et al. Among authors: snyder cl. J Med Genet. 2003 Aug;40(8):591-6. doi: 10.1136/jmg.40.8.591. J Med Genet. 2003. PMID: 12920070 Free PMC article.

9

Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer.

Lynch HT, Weisenburger DD, Quinn-Laquer B, Snyder CL, Lynch JF, Lipkin SM, Sanger WG. Lynch HT, et al. Among authors: snyder cl. Cancer Genet Cytogenet. 2002 Aug;137(1):8-14. doi: 10.1016/s0165-4608(02)00537-x. Cancer Genet Cytogenet. 2002. PMID: 12377407

10

BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.

Lynch HT, Deters CA, Snyder CL, Lynch JF, Villeneuve P, Silberstein J, Martin H, Narod SA, Brand RE. Lynch HT, et al. Among authors: snyder cl. Cancer Genet Cytogenet. 2005 Apr 15;158(2):119-25. doi: 10.1016/j.cancergencyto.2004.01.032. Cancer Genet Cytogenet. 2005. PMID: 15796958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters